Clinical Trial

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate and compare the efficacy and safety of tofacitinib and methotrexate based on prednisone therapy in patients with Takayasu arteritis
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-10-19.
Trial Details
NCT Number NCT05102448
Lead Sponsor Shanghai Zhongshan Hospital
Conditions Takayasu Arteritis
Enrollment 76 participants
Start Date 2021-11-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-15